Top Clinical Trials companies in Saudi Arabia by EBITDA
This ranking features the top 1 Clinical Trials companies in Saudi Arabia ranked by EBITDA, totaling a EBITDA of USD 46.32 M, for February 11, 2025.
Saudi Arabia
Clinical Trials
EBITDA
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 46.32 M
|
Dec. 31, 2023 | USD 8.71 | -0.52% |
|
Saudi Arabia |
Frequently Asked Questions
-
Which Clinical Trials company in Saudi Arabia has the highest EBITDA ?
The Clinical Trials company in Saudi Arabia with the highest EBITDA is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at USD 46.32 M.
-
Which Clinical Trials company in Saudi Arabia has the lowest EBITDA ?
The Clinical Trials company in Saudi Arabia with the lowest EBITDA is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at USD 46.32 M.
-
What are the top 10 Clinical Trials companies in Saudi Arabia by EBITDA ?
The top 10 Clinical Trials companies in Saudi Arabia by EBITDA are and Saudi Pharmaceutical Industries and Medical Appliances Corporation.
-
What are the bottom 10 Clinical Trials companies in Saudi Arabia by EBITDA ?
The bottom 10 Clinical Trials companies in Saudi Arabia by EBITDA are and Saudi Pharmaceutical Industries and Medical Appliances Corporation.
